Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

Authors: Kenneth G. Saag, Rachel B. Wagman, Piet Geusens, Jonathan D. Adachi, Osvaldo Daniel Messina, Ronald Emkey, Roland Chapurlat, Andrea Wang, Nicola Pannacciulli, Willem F. Lems - The Lancet 2018 cited by 204